Durect's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Durect's ROA in the second quarter of 2025?
Durect Corp recorded a cumulative net loss of $-3 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -21.13%.

However, within the Healthcare sector 364 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 3584, from total ROA ranking in the first quarter of 2025 at 3684.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	-53.79 %	-57.19 %	-68.56 %	-57.45 %	-43.82 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-3	-5	-8	-17	-16
Return On Assets (TTM)	-21.13 %	-24.4 %	-33.4 %	-49.85 %	-37.98 %
DRRX's Total Ranking	# 3584	# 3684	# 4472	# 4260	# 4094
Total Assets (TTM) in million	13	14	17	22	27
Seq. Total Assets Change	-11.82 %	-16.18 %	-21.59 %	-20.27 %	-18.31 %
Seq. Net Income Change	-	-	-	-	-

DRRX's 5 Years Annual ROA >> Back to DRRX Management Effectiveness >> Compare DRRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 130
Sector	# 365
Overall	# 3535

Return On Assets Statistics
High	Average	Low
38.92 %	-39.84 %	-85.41 %
(Dec 31 2012)		(Jun 30 2017)

Financial Statements
Durect's Assets	$ 13 million	DRRX's Balance sheet
Durect's Income	$ -2 million	Quarterly DRRX's Income Statement
DRRX's Income by Division		See DRRX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-60.33 %	-28.08 %	-32.91 %	24.9 %	-16.9 %
Total Assets in million	17	43	60	89	71
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-8	-28	-35	-36	-1
Annual Return On Assets	-48.7 %	-64.12 %	-58.99 %	-40.62 %	-0.81 %

DRRX's 5 Years Annual ROA >> Back to DRRX Management Effectiveness >> Compare DRRX ROA to its Competitors

More Return On Assets Ratios
DRRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DRRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DRRX's Competitors
Subscribers only: Roa for Durect's Suppliers
Subscribers only: Return On Assets for DRRX's Customers

You may also want to know
DRRX's Roi	DRRX's Inventory Turnover Ratio	DRRX's Growth Rates	DRRX's Dividend Comparisons
	DRRX's Profitability Ratios	DRRX's Asset Turnover Ratio	DRRX's Dividend Growth
DRRX's Roe	DRRX's Valuation Ratios	DRRX's Financial Strength Ratios	DRRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:24:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.